'Cutting by color': New imaging technique for more precise cancer surgery

Aug 19, 2008
A futuristic imaging technique could improve cancer surgery by revealing hidden anatomical details. Photo of a pig's hind leg viewed after injection with near-infrared contrast agents and imaging with near-infrared light to highlight lymph flow. Credit: John V. Frangioni, M.D., Ph.D. Beth Israel Deaconess Medical Center, Boston

Instead of "paint by number," you might call it "cutting by color": Researchers in Massachusetts now report development and early clinical trials of a new imaging system that highlights cancerous tissue in the body so that surgeons can more easily see and remove diseased tissue with less damage to normal tissue near the tumor. Their research will be presented in August at the American Chemical Society national meeting in Philadelphia.

Cancer surgeons today operate "blind" with no clear way of determining in real-time whether they have removed all of the diseased tissue, which is the key to successful surgery. Researchers in Massachusetts now report development and early clinical trials of a new imaging system that highlights cancerous tissue in the body so that surgeons can more easily see and remove diseased tissue with less damage to normal tissue near the tumor.

The technique shows particular promise for improving surgery for breast, prostate, and lung cancer, whose tumor boundaries can be difficult to track at advanced stages, they say. Described today at the 236th National Meeting of the American Chemical Society (ACS), the technique can also help cancer surgeons avoid cutting critical structures such as blood vessels and nerves.

"This technique is really the first time that cancer surgeons can see structures that are
otherwise invisible, providing true image-guided surgery," says project director John Frangioni, M.D., Ph.D., of Beth Israel Deaconess Medical Center (BIDMC) in Boston and co-director of its Center for Imaging Technology and Molecular Diagnostics. "If we're able to see cancer, we have a chance of curing it."

The system is called FLARE, or Fluorescence-Assisted Resection and Exploration. Under development for the past decade, the portable system consists of a near-infrared (NIR) imaging system, a video monitor, and a computer. "The system has no moving parts, uses LEDs instead of lasers for excitation, makes no contact with the patient, and is sterile," Frangioni says.

The unique system uses special chemical dyes, called NIR fluorophores, that are designed to target specific structures such as cancer cells when the dyes are injected into patients. When exposed to NIR light, which is invisible to the human eye, the dyes or contrast agents light up the cancer cells and are shown on a video monitor. Images of these "glowing" cancer cells are then superimposed over images of the normal surgical field, allowing surgeons to easily see the cancer cells even in a background crowded by blood and other anatomical structures, the researcher says.

Frangioni compares the system to the old color-by-number paint sets. Instead of coloring by numbers, it will provide surgeons with a means of "cutting by color," he says. The computerized technique also gives physicians the power to control multiple viewing angles and different magnification levels through the use of a footswitch.

In preliminary studies, Frangioni and colleagues used the FLARE to successfully visualize organs and body fluids of mice and map the lymph nodes of pigs, all in real-time. The first human clinical trials, expected to begin this summer, involve mapping the lymph nodes of a small group of patients with breast cancer. Broader clinical use of the device could occur within five years, the researchers estimate.

In the future, fluorophores could be developed to highlight nerves and blood vessels in one color while visualizing cancer cells in a different color, allowing multiple structures to be viewed easily and even simultaneously, he says.

"The future of the technology now is really in the chemistry," Frangioni says. "We have to develop agents for specific tumors, nerves or blood vessels we're trying to visualize."

Source: ACS

Explore further: Oat breakfast cereals may contain a common mold-related toxin

add to favorites email to friend print save as pdf

Related Stories

3-D printers to make human body parts? It's happening

Feb 04, 2015

It sounds like something from a science fiction plot: So-called three-dimensional printers are being used to fashion prosthetic arms and hands, jaw bones, spinal-cord implants - and one day perhaps even living human body ...

Recommended for you

Oat breakfast cereals may contain a common mold-related toxin

Feb 25, 2015

Oats are often touted for boosting heart health, but scientists warn that the grain and its products might need closer monitoring for potential mold contamination. They report in ACS' Journal of Agricultural and Food Chemistry that s ...

NETL invents improved oxygen carriers

Feb 24, 2015

One of the keys to the successful deployment of chemical looping technologies is the development of affordable, high performance oxygen carriers. One potential solution is the naturally-occurring iron oxide, ...

Research could make blue jeans green

Feb 23, 2015

Who doesn't like blue jeans? They're practically wrinkle-proof. The indigo dye that provides their distinctive color holds up to detergents, but ages into that soft, worn look. No wonder the average American ...

Novel electrode boosts green hydrogen research

Feb 20, 2015

Scientists from the National Physical Laboratory (NPL) have developed a novel reference electrode, and are working with hydrogen energy system manufacturer ITM Power to aid the development of hydrogen production ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.